276 related articles for article (PubMed ID: 28459057)
1. Chlamydial Type III Secretion System Needle Protein Induces Protective Immunity against
Koroleva EA; Kobets NV; Shcherbinin DN; Zigangirova NA; Shmarov MM; Tukhvatulin AI; Logunov DY; Naroditsky BS; Gintsburg AL
Biomed Res Int; 2017; 2017():3865802. PubMed ID: 28459057
[No Abstract] [Full Text] [Related]
2. Immunization with chlamydial type III secretion antigens reduces vaginal shedding and prevents fallopian tube pathology following live C. muridarum challenge.
Bulir DC; Liang S; Lee A; Chong S; Simms E; Stone C; Kaushic C; Ashkar A; Mahony JB
Vaccine; 2016 Jul; 34(34):3979-85. PubMed ID: 27325352
[TBL] [Abstract][Full Text] [Related]
3. Multistage vaccines containing outer membrane, type III secretion system and inclusion membrane proteins protects against a Chlamydia genital tract infection and pathology.
O'Meara CP; Armitage CW; Andrew DW; Kollipara A; Lycke NY; Potter AA; Gerdts V; Petrovsky N; Beagley KW
Vaccine; 2017 Jul; 35(31):3883-3888. PubMed ID: 28602608
[TBL] [Abstract][Full Text] [Related]
4. Antigen-specific CD4+ T cells produce sufficient IFN-gamma to mediate robust protective immunity against genital Chlamydia muridarum infection.
Li W; Murthy AK; Guentzel MN; Seshu J; Forsthuber TG; Zhong G; Arulanandam BP
J Immunol; 2008 Mar; 180(5):3375-82. PubMed ID: 18292563
[TBL] [Abstract][Full Text] [Related]
5. Expression library immunization confers partial protection against Chlamydia muridarum genital infection.
McNeilly CL; Beagley KW; Moore RJ; Haring V; Timms P; Hafner LM
Vaccine; 2007 Mar; 25(14):2643-55. PubMed ID: 17239501
[TBL] [Abstract][Full Text] [Related]
6. Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG/HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infection.
Brown TH; David J; Acosta-Ramirez E; Moore JM; Lee S; Zhong G; Hancock RE; Xing Z; Halperin SA; Wang J
Vaccine; 2012 Jan; 30(2):350-60. PubMed ID: 22075089
[TBL] [Abstract][Full Text] [Related]
7. Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.
Murthy AK; Chambers JP; Meier PA; Zhong G; Arulanandam BP
Infect Immun; 2007 Feb; 75(2):666-76. PubMed ID: 17118987
[TBL] [Abstract][Full Text] [Related]
8. Immunization with chlamydial plasmid protein pORF5 DNA vaccine induces protective immunity against genital chlamydial infection in mice.
Li Z; Wang S; Wu Y; Zhong G; Chen D
Sci China C Life Sci; 2008 Nov; 51(11):973-80. PubMed ID: 18989639
[TBL] [Abstract][Full Text] [Related]
9. Intranasal vaccination with Chlamydia pneumoniae induces cross-species immunity against genital Chlamydia muridarum challenge in mice.
Manam S; Chaganty BK; Evani SJ; Zafiratos MT; Ramasubramanian AK; Arulanandam BP; Murthy AK
PLoS One; 2013; 8(5):e64917. PubMed ID: 23741420
[TBL] [Abstract][Full Text] [Related]
10. Immunization with live and dead Chlamydia muridarum induces different levels of protective immunity in a murine genital tract model: correlation with MHC class II peptide presentation and multifunctional Th1 cells.
Yu H; Karunakaran KP; Kelly I; Shen C; Jiang X; Foster LJ; Brunham RC
J Immunol; 2011 Mar; 186(6):3615-21. PubMed ID: 21296978
[TBL] [Abstract][Full Text] [Related]
11. Induction of cross-serovar protection against genital chlamydial infection by a targeted multisubunit vaccination approach.
Li W; Guentzel MN; Seshu J; Zhong G; Murthy AK; Arulanandam BP
Clin Vaccine Immunol; 2007 Dec; 14(12):1537-44. PubMed ID: 17942608
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with the polymorphic membrane protein A reduces Chlamydia muridarum induced genital tract pathology.
Müller T; Becker E; Stallmann S; Waldhuber A; Römmler-Dreher F; Albrecht S; Mohr F; Hegemann JH; Miethke T
Vaccine; 2017 May; 35(21):2801-2810. PubMed ID: 28413133
[TBL] [Abstract][Full Text] [Related]
13. Protective immunity against mouse upper genital tract pathology correlates with high IFNγ but low IL-17 T cell and anti-secretion protein antibody responses induced by replicating chlamydial organisms in the airway.
Lu C; Zeng H; Li Z; Lei L; Yeh IT; Wu Y; Zhong G
Vaccine; 2012 Jan; 30(2):475-85. PubMed ID: 22079265
[TBL] [Abstract][Full Text] [Related]
14. Induction of protective immunity against Chlamydia muridarum intravaginal infection with a chlamydial glycogen phosphorylase.
Li Z; Lu C; Peng B; Zeng H; Zhou Z; Wu Y; Zhong G
PLoS One; 2012; 7(3):e32997. PubMed ID: 22427926
[TBL] [Abstract][Full Text] [Related]
15. A vaccine formulated with the major outer membrane protein can protect C3H/HeN, a highly susceptible strain of mice, from a Chlamydia muridarum genital challenge.
Pal S; Tatarenkova OV; de la Maza LM
Immunology; 2015 Nov; 146(3):432-43. PubMed ID: 26423798
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine.
Ifere GO; He Q; Igietseme JU; Ananaba GA; Lyn D; Lubitz W; Kellar KL; Black CM; Eko FO
J Microbiol Immunol Infect; 2007 Jun; 40(3):188-200. PubMed ID: 17639158
[TBL] [Abstract][Full Text] [Related]
17. The
Verma R; Sahu R; Dixit S; Duncan SA; Giambartolomei GH; Singh SR; Dennis VA
Front Immunol; 2018; 9():2369. PubMed ID: 30374357
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the nine polymorphic membrane proteins of Chlamydia trachomatis for their ability to induce protective immune responses in mice against a C. muridarum challenge.
Pal S; Favaroni A; Tifrea DF; Hanisch PT; Luczak SET; Hegemann JH; de la Maza LM
Vaccine; 2017 May; 35(19):2543-2549. PubMed ID: 28385608
[TBL] [Abstract][Full Text] [Related]
19. Protection against Chlamydia promoted by a subunit vaccine (CTH1) compared with a primary intranasal infection in a mouse genital challenge model.
Olsen AW; Theisen M; Christensen D; Follmann F; Andersen P
PLoS One; 2010 May; 5(5):e10768. PubMed ID: 20505822
[TBL] [Abstract][Full Text] [Related]
20. Comparison of intranasal and transcutaneous immunization for induction of protective immunity against Chlamydia muridarum respiratory tract infection.
Skelding KA; Hickey DK; Horvat JC; Bao S; Roberts KG; Finnie JM; Hansbro PM; Beagley KW
Vaccine; 2006 Jan; 24(3):355-66. PubMed ID: 16153755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
